阻塞性睡眠呼吸暂停
医学
肥胖
睡眠呼吸暂停
呼吸暂停-低通气指数
体质指数
减肥
呼吸暂停
呼吸不足
麻醉
内科学
多导睡眠图
作者
Brian W. Locke,Ainhoa Gómez-Lumbreras,Chia Jie Tan,Teerawat Nonthasawadsri,Nathorn Chaiyakunapruk,Chanthawat Patikorn,N Chaiyakunapruk
摘要
Summary Introduction Weight loss is recommended for individuals with obstructive sleep apnea (OSA) and overweight or obesity, but there is limited evidence to guide the selection of weight management strategies for patients who do not lose sufficient weight with diet and lifestyle changes. We evaluated the relationship between weight loss caused by pharmacologic or surgical interventions and subsequent improvement in OSA by the apnea‐hypopnea index (AHI). Methods PubMed, Cochrane CENTRAL, and EMBASE were searched for randomized trials comparing pharmacologic or surgical obesity interventions to usual care, placebo, or no treatment in adults with OSA. The association between percentage weight loss and AHI change between randomization and last follow‐up was evaluated using meta‐regression. PROSPERO: CRD42022378853. Results Ten eligible trials ( n = 854 patients) were included. Four ( n = 211) assessed bariatric surgery, and 6 ( n = 643) assessed pharmacologic interventions over a median follow‐up of 13 months (interquartile range 6–26 months). The linear best estimate of the change in AHI is 0.45 events per hour (95% Confidence Interval 0.18 to 0.73 events per hour) for every 1% body weight lost. Conclusions Weight loss caused by medication or surgery caused a proportionate improvement of the AHI. Providers could consider extrapolating from this relationship when advising patients of the expected effects of other pharmacologic or surgical interventions without direct evidence in OSA.
科研通智能强力驱动
Strongly Powered by AbleSci AI